Work

Targeting HDAC6 Is a Novel Approach to Augment the Therapeutic Benefit of Bromodomain Inhibition in Multiple Myeloma

Year: 2014

Type: article

Source: Blood

DOI: 10.1182/blood.v124.21.4760.4760

Authors: Jennifer S. Carew, Claudia M. Espitia, Weiguo Zhao, Kevin R. Kelly, Steffan T. Nawrocki

Institutions: Cleveland Clinic, The University of Texas at San Antonio Health Science Center, University of Southern California

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588726445

FWCI: 0.205

Cites:

Cited by: 1

Related to: 10